GeneThera Financial Statements From 2010 to 2025
| GTHR Stock | USD 0.0001 0.00 0.00% |
Check GeneThera financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneThera's main balance sheet or income statement drivers, such as , as well as many indicators such as . GeneThera financial statements analysis is a perfect complement when working with GeneThera Valuation or Volatility modules.
GeneThera |
GeneThera Company Shares Outstanding Analysis
GeneThera's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current GeneThera Shares Outstanding | 35.33 M |
Most of GeneThera's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GeneThera is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, GeneThera has 35.33 M of shares currently outstending. This is 80.43% lower than that of the Healthcare sector and 66.93% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 93.82% higher than that of the company.
GeneThera Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GeneThera's current stock value. Our valuation model uses many indicators to compare GeneThera value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GeneThera competition to find correlations between indicators driving GeneThera's intrinsic value. More Info.GeneThera is rated # 2 in return on asset category among its peers. It also is rated # 2 in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GeneThera's earnings, one of the primary drivers of an investment's value.About GeneThera Financial Statements
GeneThera shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although GeneThera investors may analyze each financial statement separately, they are all interrelated. The changes in GeneThera's assets and liabilities, for example, are also reflected in the revenues and expenses on on GeneThera's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of zoonotic diseases. The companys Molecular RoboticAI Platform and Therapeutic strategy is designed to prevent the spread of disease from animals and allow to better control of zoonotic infectious agents. Genethera operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
Pair Trading with GeneThera
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if GeneThera position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneThera will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to GeneThera could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GeneThera when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GeneThera - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GeneThera to buy it.
The correlation of GeneThera is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GeneThera moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GeneThera moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GeneThera can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for GeneThera Pink Sheet Analysis
When running GeneThera's price analysis, check to measure GeneThera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneThera is operating at the current time. Most of GeneThera's value examination focuses on studying past and present price action to predict the probability of GeneThera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneThera's price. Additionally, you may evaluate how the addition of GeneThera to your portfolios can decrease your overall portfolio volatility.